Chinook Therapeutics, Inc. announced the appointment of Charlotte Jones-Burton, M.D., M.S. as senior vice president of product development and strategy. Dr. Jones-Burton joins Chinook from Otsuka Pharmaceuticals, where she most recently served as vice president of global clinical development and head of nephrology. She has spent over a decade in the pharmaceutical industry, including at Bristol-Myers Squibb and Merck, where she led clinical trial development for multiple medicines across various disease areas including cardiovascular and renal diseases.
Chinook Therapeutics, Inc.
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |